Skip to main content

Advertisement

SpringerLink
Log in

Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–2390

    Article  CAS  Google Scholar 

  2. Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE (1991) P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer 49(5):696–703

    Article  CAS  Google Scholar 

  3. Dunleavy K, Pittaluga S, Maeda LS et al (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368(15):1408–1416

    Article  CAS  Google Scholar 

  4. Giulino-Roth L, O’Donohue T, Chen Z et al (2017) Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol 179(5):739–747

    Article  CAS  Google Scholar 

  5. Ganesan P, Ganesan TS, Atreya H et al (2018) DA-EPOCH-R in aggressive CD 20 positive B cell lymphomas: real-world experience. Indian J Hematol Blood Transf 34(3):454–459

    Article  Google Scholar 

  6. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068

    Article  Google Scholar 

  7. Giulino-Roth L (2018) How I treat primary mediastinal B-cell lymphoma. Blood 132(8):782–790

    Article  CAS  Google Scholar 

  8. Zinzani PL, Broccoli A, Casadei B et al (2015) The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients. Hematol Oncol 33(4):145–150

    Article  CAS  Google Scholar 

  9. Gleeson M, Hawkes EA, Cunningham D et al (2016) Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial. Br J Haematol 175(4):668–672

    Article  CAS  Google Scholar 

  10. Aoki T, Izutsu K, Suzuki R et al (2013) Novel prognostic model of primary mediastinal large B-cell lymphoma (PMBL): a multicenter cooperative retrospective study in Japan. ASH Annu Meet Abstr 122(21):638

    Google Scholar 

Download references

Funding

No funding received for the study.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, BRA, IRCH, All India Institute of Medical Sciences (AIIMS), New Delhi, Room No. 218, New Delhi, India

    Ajay Gogia, Sudhir Kumar & Santosh Kumar Chellapurum

  2. Department of Radiation Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India

    Ahitagni Biswas

  3. Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, New Delhi, India

    Soumya Mallick

Authors
  1. Ajay Gogia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sudhir Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Santosh Kumar Chellapurum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ahitagni Biswas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Soumya Mallick
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ajay Gogia.

Ethics declarations

Conflict of Interest

No potential conflict of interest.

Ethical Approval

Institute ethical clearance was obtained for the retrospective study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gogia, A., Kumar, S., Chellapurum, S.K. et al. Primary Mediastinal B Cell Lymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol. Indian J Hematol Blood Transfus 37, 176–178 (2021). https://doi.org/10.1007/s12288-020-01301-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-020-01301-z

Search

Navigation